Recombinant PSP94 (prostate secretory protein of 94 amino acids) demonstrates similar linear epitope structure as natural PSP94 protein

Journal of Cellular Biochemistry

Volumn 63, Issue 1, 1996, Pages 61-73

  Xuan, Jim W ^a,c   Wu, Dongmei ^a   Guo, Yuzhen ^b   Fraser, Jennifer E ^b   Chin, Joseph L ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Procyon Biopharma Inc   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

antigen binding; competitive ELISA; ELISA; immunoassay; linear epitope; peptide mapping; recombinant GST PSP94

Indexed keywords

SECRETORY PROTEIN;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; ESCHERICHIA COLI; HUMAN; IMMUNOGENICITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN CONFORMATION; PROTEIN DETERMINATION; SEQUENCE ANALYSIS;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; ESCHERICHIA COLI; GLUTATHIONE TRANSFERASE; PROSTATIC SECRETORY PROTEINS; PROTEINS; RABBITS; SEMINAL PLASMA PROTEINS; SPERM IMMOBILIZING AGENTS;

ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS;

EID: 0029740711     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199610)63:1<61::AID-JCB5>3.0.CO;2-Y     Document Type: Article

References (42)

1. Abrahamsson P-A, Lilja H, Falkmer S, Wadstrom LB (1988): Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 12:39-46.
2. Akiyama K, Yoshioka Y, Schmid K, Offner GD, Troxler RF, Tsunda R, Hara M (1985): The amino acid sequence of human β-microseminoprotein. Biochem Biophys Res Commun 829:288-294.
3. Bautista DS, Xuan JW, Hota C, Chambers AF, Harris JF (1994): Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin. J Biol Chem 269:23280-23285.
4. Brar A, Mbikay M, Sirois F, Fournier S, Seidah NG, Chretien M (1988): Localization of the human prostatic secretory protein PSP94 and its mRNA in the epithelial cells of the prostate. J Androl 9:253-260.
5. Carter D, Resnick MI (1982): High resolution analysis of human prostatic fluid by two-dimensional electrophoresis. Prostate 3:27-33.
6. Doctor VM, Sheth AR, Simha MM, Arbatti NJ, Aaveri JP, Sheth NA (1986): Studies on immunocytochemical localization of inhibin-like material in human prostate tissue: Comparison of its distribution in normal, benign and malignant prostates. Br J Cancer 53:547-554.
7. Dube JY, Frenette G, Paquin R, Chapdelaine P, Tremblay J, Tremblay RR, Lazure C, Seidah N, Chretien M (1987): Isolation from human seminal plasma of an abundant 16-kDa protein originating from the prostate, its identification with a 94-residue peptide originally described as β-inhibin. J Androl 8:182-189.
8. Fridman WH (1991): Fc receptors and immunoglobulin binding factors. FASEB J 5:2684-2690.
9. Frorath B, Abney CC, Berthold H, Scanarini M, Northemann W (1992): Production of recombinant rat interleukin-6 in Escherichia coli using a novel highly efficient expression vector pGEX-3T. BioTechniques 12:558-563.
10. Garde S, Sheth A, Porter AT, Pienta KJ (1993a): Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and vivo. Prostate 22:225-233.
11. Garde SV, Sheth AR, Porter AT, Pienta KJ (1993b): A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett 70:159-166.
12. Green CB, Liu WY, Kwok Simon CM (1990): Cloning and nucleotide sequence analysis of the human β-microseminoprotein gene. Biochem Biophys Res Commun 167:1184-1190.
13. Hara M, Kimura H (1989): Two prostate-specific antigens, γ-seminoprotein and β-microseminoprotein. J Lab Clin Med 113:541-548.
14. Huang C-L, Brassil D, Rozzel M, Schellhammer PF, Wright GL Jr (1993): Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma. Prostate 23:201-212.
15. Huang C-L, Liang HM, Brassil D, Schellhammer PF, Rozzel M, Newhall K, Beckett ML, Wright GL Jr (1992): Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serum. Clin Chem 38:817-823.
16. Johansson J, Sheth A, Cederlund E, Jornvall H (1984): Analysis of an inhibin preparation reveals apparent identity between a peptide with inhibin-like activity and a sperm-coating antigen. FEBS Lett 176:21-26.
17. Liang ZG, Kamada M, Koide SS (1991): Structural identity of immunoglobulin binding factor and prostatic secretory protein of human seminal plasma. Biochem Biophys Res Commun 180:356-359.
18. Liang ZG, Kamada M, Mitsudo SM, Koide SS (1992): Immunoglobulin binding factor of seminal plasma: A secretory product of human prostate. Arch Androl 28:159-164.
19. Lokeshwar BL, Hurkadli KS, Sheth AR, Block NL (1993): Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor. Cancer Res 53:4855-4859.
20. MaedaN, Kamada M, Daitoh T, Aono T, Futaki S, Liang ZG, Koide SS (1993): Immunoglobulin binding factor in human seminal plasma: immunological function. Arch Androl 31:31-36.
21. Maeda N, Kamada M, Daitoh T, Maegawa M, Hirano K, Aono T, Shiotsu T, Kanayama H, Kagawa S, Futaki S, Muraguchi M, Ohmoto Y, Liang ZG, Koide SS (1994): Immunoglobulin binding factor: A tumor marker for prostatic tumors. Prostate 24:125-130.
22. Mbikay M, Linard CG, Sirois F, Lazure C, Seidah NG, Chretien M (1988): Tissue-specific expression of the prostatic secretory protein PSP94 in cyanomolgus monkey (Macaca fascicularis). Cell Mol Biol 34:387-398.
23. Mbikay M, Nolet S, Fournier S, Benjannet S, Chapdelaine P, Paradis G, Dube Jean Y, Tremblay R, Lazure C, Seidah NS, Chretien M (1987): Molecular cloning and sequence of the cDNA for a 94-amino-acid seminal plasma protein secreted by the human prostate. DNA 6:23-29.
24. Mundel SD, Shedth NA (1993): Suppression of DNA synthesis and induction of apoptosis in rat prostate by human seminal plasma inhibin (HSPI). Cell Biol Int 17:587-594.
25. Nolet S, Mbikay M, Chretien M (1991): Prostatic secretory protein PSP94: Gene organization and promoter sequence in Rhesus monkey and human. Biochim Biophys Acta 1089:247-249.
26. Ochiai Y, Inazawa J, Ueyama H, Ohkubo I (1995): Human gene for beta-microseminoprotein: its promoter structure and chromosomal localization. J Biochem 117:346-352.
27. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning: A Laboratory Manual." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
28. Seidah NG, Arbatti NJ, Rochemont J, Sheth AR, Chretien M (1984): Complete amino acid sequence of human seminal plasma β-inhibin. FEBS Lett 175:349-355.
29. Sheth AR, Teni TR, Sheth NR (1988): Human prostate inhibin. In Emura H, et al (eds): "Progress in Endocrinology." New York: Elsevier B.V., Biomedical Division, pp 301-306.
30. Sheth NA, Doctor VM, Sampat MB, Garde SV, Arbatti NJ, Sheth AR (1987): Inhibin-like material - an immunohistological marker for prostatic origin of metastases. Cancer Lett 36:93-98.
31. Teni TR, Sheth AR, Kamath MR, Sheth NA (1988): Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate. Cancer Lett 43:9-14.
32. Teni TR, Bandivdekar AH, Sheth AR, Sheth NA (1989): Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay. Clin Chem 35:1376-1379.
33. Tremblay J, Frenette G, Tremblay RR, Dupont A, Thabet M, Dube JY (1987): Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypotrophy or prostate cancer. Prostate 10:235-243.
34. Ulvsback M, Lindstrom C, Weiber H, Abrahamsson P-A, Lilja H, Lundwall A (1989): Molecular cloning of a small prostate protein, known as β-microsemenoprotein, PSP94 or β-inhibin, and demonstration of transcripts in nongenital tissues. Biochem Biophys Res Commun 164:1310-1315.
35. Ulvsback M, Spurr NK, Lundwall A (1991): Assignment of the human gene for β-microseminoprotein (MSMB) to chromosome 10 and demonstration of related genes in other vertebrates. Genomics 11:92-924.
36. Vanage GR, Garde SV, Sheth AR, Gopalkrishnan K (1992): Passive immunization against prostatic "inhibin" peptide as a male contraceptive. Int J Androl 15:114-126.
37. Vaze AY, Thakur AN, Sheth AR (1979): Development of a radioimmunoassay for human seminal plasma inhibin. J Reprod Fertil (suppl) 26:135-146.
38. Wright GL Jr, Huang CL, Lipford G, Beckett ML, Liang HM, Haley C, Newhall K, Morningstar M (1990): Generation and characterization of monoclonal antibodies to prostate secretory protein. Int J Cancer 46:39-49.
39. Xuan JW, Hota C, Chambers AF (1994): Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion. J Cell Biochem 54:247-255.
40. Xuan JW, Chin JL, Guo Y, Chambers AF, Finkelman MA, Clarke MW (1995a): Alternative splicing of PSP94 (prostate secretory protein of 94 amino acids) mRNA in prostate tissue. Oncogene 11:1041-1047.
41. Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF (1995b): Site-directed mutagenesis of Arginine-Glycine-Aspartic acid sequence in osteopontin destroys cell adhesion and migration function. J Cell Biochem 57:680-690.
42. Xuan JW, Wilson SM, Chin JL, Chambers AF (1995c): Metastatic NIH 3T3 X LTA cell hybrids express 72 kDa Type FV collagenase. Anticancer Res 15:1227-1234.